Tumor-associated macrophages (TAMs) promote tumor progression in liver tissue microenvironments by releasing IL-6, which, in turn, activates the IL-6/STAT3 signaling pathway in nearby HCC stem cells [82]. Here, IL6 is linked to hepatocellular carcinoma.